FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Multiple Sclerosis
Related studies linked through entity extraction aliases.
Experimental Evaluation of Wheelchair-Mounted Robotic Arms
- Status
- COMPLETED
- Phase
- N/A
Prognosis Value of the Neuronal Damage in Early Multiple Sclerosis
- Status
- UNKNOWN
- Phase
- NA
MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study)
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Assessing Tolerability of Avonex Intramuscular Injections
- Status
- COMPLETED
- Phase
- NA
Safety Study of GNbAC1 in Multiple Sclerosis Patients
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Intervention Responsiveness in People With Multiple Sclerosis
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination
- Status
- UNKNOWN
- Phase
- PHASE2
Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active Control
- Status
- COMPLETED
- Phase
- N/A
Study of Alemtuzumab in Treatment Refractory MS Subjects/Alemtuzumab Naive & Alemtuzumab Experienced Subjects
- Status
- UNKNOWN
- Phase
- PHASE1
ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against Interferon
- Status
- WITHDRAWN
- Phase
- PHASE4
Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility
- Status
- COMPLETED
- Phase
- N/A
Study of Lisdexamfetamine Sulfate to Treat Cognitive Dysfunction in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
The Role of Exercise in Modifying Outcomes for People With Multiple Sclerosis
- Status
- UNKNOWN
- Phase
- NA
An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients
- Status
- COMPLETED
- Phase
- PHASE3
A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Stem Cells in Rapidly Evolving Active Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin
- Status
- COMPLETED
- Phase
- PHASE3